{"database": "openregs", "table": "documents", "rows": [["FDA-2015-D-1211-0405", "FDA", "FDA-2015-D-1211", "Reference 44_New Ref 44_HIV incidence in US first-time blood donors during 12-month and 3-month MSM deferral policy periods re: Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products Guidance for Industry", "Supporting & Related Material", "Background Material", "2023-05-12T04:00:00Z", 2023, 5, null, null, "2023-05-12T20:08:01Z", null, 0, 0, "09000064859fd944"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2015-D-1211-0405"], "units": {}, "query_ms": 116.35824700351804, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}